See also this year's filing and all EDGAR filings for this company.
PDF Report 0001260990_2016_Oncternal_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001260990, Oncternal Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 31,889,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 5,000 |
| 3 | remainder_Assets | 137,000 |
| 4 | LiabilitiesCurrent | 30,172,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,500,264 |
| 9 | ResearchAndDevelopmentExpense | 10,933,724 |
| 10 | remainder_Expenses | 939,603 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -36,827 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 32,031,000 |
| 1 | Liabilities | 30,172,000 |
| 2 | Expenses | 20,373,591 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 1,859,000 |
| 5 | NetIncome | -20,410,418 |
| 6 | ComprehensiveNetIncome | -20,410,418 |
| 7 | BaseVar | 41,306,709 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.526 |
| 9 | EconomicCapitalRatio | 1.38 |